Tenaya Therapeutics, Inc.: insider trading
128 trades by 16 directors, officers and 10% owners since 2021, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$6.0 M
34 sales by 5 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$2 K
2 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (16)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Faraz AliChief Executive Officer, Director | 536,283 | — | $29 K | |
| Whittemore TingleyChief Medical Officer | 259,850 | — | $12 K | |
| Tomohiro HigaSVP, Finance | 118,267 | — | $3 K | |
| TCG Opportunity III GP, LLC10% owner | — | — | $2.4 M | |
| Column Group Iii-A, LP10% owner | — | — | $3.5 M | |
| Column Group III, LP10% owner | — | — | — | |
| David V. GoeddelDirector, 10% owner | — | — | — | |
| Chihiro SaitoSVP, Accounting and Fin. Ops. | 60,983 | — | — | |
| Timothy HoeyChief Scientific Officer | 245,346 | — | — | |
| Leone D. PattersonChief Fin. and Bus. Officer | 95,755 | — | — | |
| Column Group III GP, LP10% owner | — | — | — | |
| Deepak SrivastavaDirector | — | — | — | |
| Casdin Capital, LLCDirector | — | — | — | |
| Casdin Private Growth Equity Fund, L.P.10% owner | — | — | — | |
| Eli CasdinDirector, 10% owner | — | — | — | |
| JeenJoo KangDirector | 25,000 | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,499 | $0.321 | $1 K | 536,283 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -3,223 | $0.321 | $1 K | 259,850 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Grant or award | +49,000 | — | — | 263,073 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Grant or award | +122,000 | — | — | 539,782 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,637 | $0.710 | $1 K | 219,860 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,837 | $0.710 | $4 K | 434,177 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,969 | $0.710 | $3 K | 430,208 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,637 | $0.710 | $1 K | 218,223 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,871 | $0.710 | $1 K | 216,352 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,020 | $0.710 | $4 K | 425,188 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -2,279 | $0.710 | $2 K | 214,073 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -7,406 | $0.710 | $5 K | 417,782 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -3,121 | $0.790 | $2 K | 215,497 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,390 | $0.790 | $3 K | 440,014 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -1,485 | $0.790 | $1 K | 118,267 | Form 4 |
| filed | TCG Opportunity III GP, LLC10% owner | Sellindirect | -1.65 M | $0.560 | $924 K | 0 | Form 4 |
| filed | TCG Opportunity III GP, LLC10% owner | Sellindirect | -1.86 M | $0.560 | $1.0 M | 0 | Form 4 |
| filed | TCG Opportunity III GP, LLC10% owner | Sellindirect | -309,228 | $0.620 | $192 K | 1.65 M | Form 4 |
| filed | TCG Opportunity III GP, LLC10% owner | Sellindirect | -349,212 | $0.620 | $217 K | 1.86 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -143,709 | $0.600 | $86 K | 1.96 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -162,291 | $0.600 | $97 K | 2.21 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -245,965 | $0.610 | $150 K | 2.10 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -277,769 | $0.610 | $169 K | 2.37 M | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,642 | $0.640 | $1 K | 222,136 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -611 | $0.640 | $391 | 122,610 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,851 | $0.640 | $4 K | 452,415 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -836 | $0.640 | $535 | 121,774 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,979 | $0.640 | $3 K | 448,436 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,642 | $0.640 | $1 K | 220,494 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -2,022 | $0.640 | $1 K | 119,752 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,876 | $0.640 | $1 K | 218,618 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,032 | $0.640 | $3 K | 443,404 | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -1.91 M | $0.680 | $1.3 M | 2.35 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -2.15 M | $0.680 | $1.5 M | 2.65 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -161,422 | $0.820 | $132 K | 4.25 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Sellindirect | -182,295 | $0.820 | $149 K | 4.80 M | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Grant or award | +48,750 | — | — | 223,778 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Grant or award | +29,250 | — | — | 123,221 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Grant or award | +158,600 | — | — | 458,266 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -1,367 | $1.330 | $2 K | 93,971 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,126 | $1.330 | $4 K | 299,666 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -2,877 | $1.330 | $4 K | 169,926 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,720 | $1.250 | $7 K | 311,605 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -523 | $1.250 | $654 | 97,777 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,608 | $1.250 | $2 K | 176,248 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -717 | $1.250 | $896 | 97,060 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,893 | $1.250 | $5 K | 307,712 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,608 | $1.250 | $2 K | 174,640 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -1,722 | $1.250 | $2 K | 95,338 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,837 | $1.250 | $2 K | 172,803 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -4,920 | $1.250 | $6 K | 302,792 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,189 | $0.440 | $1 K | 317,325 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -1,390 | $0.440 | $612 | 98,300 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -2,937 | $0.440 | $1 K | 171,856 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -1,017 | $0.540 | $549 | 101,155 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,727 | $0.540 | $933 | 180,464 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,794 | $0.540 | $3 K | 324,461 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -620 | $0.540 | $335 | 100,535 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -4,073 | $0.540 | $2 K | 176,391 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,947 | $0.540 | $2 K | 320,514 | Form 4 |
| filed | Tomohiro HigaSVP, Finance | Sell | -845 | $0.540 | $456 | 99,690 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,598 | $0.540 | $863 | 174,793 | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +35.71 M | $0.700 | $25.0 M | 49.31 M | Form 4 |
| filed | Column Group III, LP10% owner | Buyindirect | +35.71 M | $0.700 | — | 49.31 M | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Grant or award | +107,500 | — | — | 295,831 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Grant or award | +34,424 | — | — | 330,255 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Grant or award | +40,000 | — | — | 147,106 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Grant or award | +31,676 | — | — | 178,782 | Form 4 |
| filed | Chihiro SaitoSVP, Accounting and Fin. Ops. | Sell | -2,258 | $2.120 | $5 K | 60,983 | Form 4 |
| filed | Chihiro SaitoSVP, Accounting and Fin. Ops. | Sell | -902 | $2.890 | $3 K | 64,702 | Form 4 |
| filed | Chihiro SaitoSVP, Accounting and Fin. Ops. | Sell | -654 | $2.890 | $2 K | 64,048 | Form 4 |
| filed | Chihiro SaitoSVP, Accounting and Fin. Ops. | Sell | -807 | $2.890 | $2 K | 63,241 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,802 | $2.890 | $17 K | 192,277 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -5,803 | $2.890 | $17 K | 108,731 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -3,946 | $2.890 | $11 K | 188,331 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -1,625 | $2.890 | $5 K | 107,106 | Form 4 |
| filed | Chihiro SaitoSVP, Accounting and Fin. Ops. | Grant or award | +25,000 | — | — | 65,604 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Sell10b5-1 plan | -3,300 | $7.000 | $23 K | 245,346 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Grant or award | +35,000 | — | — | 108,534 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Grant or award | +85,000 | — | — | 198,079 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Grant or award | +12,500 | — | — | 248,646 | Form 4 |
| filed | Leone D. PattersonChief Fin. and Bus. Officer | Grant or award | +35,000 | — | — | 95,755 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Sell10b5-1 plan | -6,369 | $5.310 | $34 K | 236,346 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Sell10b5-1 plan | -200 | $6.170 | $1 K | 236,146 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -6,500 | $5.860 | $38 K | 73,534 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -6,358 | $5.860 | $37 K | 113,079 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Sell | -4,681 | $5.860 | $27 K | 242,715 | Form 4 |
| filed | Leone D. PattersonChief Fin. and Bus. Officer | Sell | -5,201 | $5.860 | $30 K | 60,755 | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +2.22 M | $4.500 | $10.0 M | 13.60 M | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Buyindirect | +2.22 M | $4.500 | — | 13.60 M | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Sell10b5-1 plan | -7,243 | $4.260 | $31 K | 247,396 | Form 4 |
| filed | Leone D. PattersonChief Fin. and Bus. Officer | Sell | -4,452 | $3.810 | $17 K | 64,542 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Sell | -4,007 | $3.810 | $15 K | 254,639 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Sell | -5,563 | $3.810 | $21 K | 119,437 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Sell | -5,563 | $3.810 | — | 76,437 | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +6,779 | $2.600 | $18 K | 11.38 M | Form 4 |
| filed | Column Group III, LP10% owner | Buyindirect | +6,779 | $2.600 | — | 11.38 M | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Grant or award | +35,000 | — | — | 35,000 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Grant or award | +30,000 | — | — | 228,646 | Form 4 |
| filed | Faraz AliChief Executive Officer, Director | Grant or award | +125,000 | — | — | 125,000 | Form 4 |
| filed | Leone D. PattersonChief Fin. and Bus. Officer | Grant or award | +30,000 | — | — | 32,000 | Form 4 |
| filed | Whittemore TingleyChief Medical Officer | Grant or award | +45,000 | — | — | 80,000 | Form 4 |
| filed | Leone D. PattersonChief Fin. and Bus. Officer | Grant or award | +35,000 | — | — | 67,000 | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Grant or award | +30,000 | — | — | 258,646 | Form 4 |
| filed | Column Group Iii-A, LP10% owner | Buyindirect | +1.50 M | $2.600 | — | 11.37 M | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +1.50 M | $2.600 | $3.9 M | 11.37 M | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +69,739 | $2.500 | $174 K | 9.87 M | Form 4 |
| filed | Column Group III GP, LP10% owner | Buyindirect | +69,739 | $2.500 | — | 9.87 M | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +135,688 | $2.520 | $342 K | 9.80 M | Form 4 |
| filed | Column Group III GP, LP10% owner | Buyindirect | +135,688 | $2.520 | — | 9.80 M | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +49,463 | $2.490 | $123 K | 9.66 M | Form 4 |
| filed | Column Group III GP, LP10% owner | Buyindirect | +49,463 | $2.490 | — | 9.66 M | Form 4 |
| filed | Deepak SrivastavaDirector | Buyindirect | +230,769 | $2.600 | $600 K | 372,435 | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Buyindirect | +9.62 M | $2.600 | $25.0 M | 9.62 M | Form 4 |
| filed | Column Group III, LP10% owner | Buyindirect | +9.62 M | $2.600 | — | 9.62 M | Form 4 |
| filed | Casdin Capital, LLCDirector | Buyindirect | +2.49 M | $2.600 | $6.5 M | 6.08 M | Form 4 |
| filed | Timothy HoeyChief Scientific Officer | Sell10b5-1 plan | -1,353 | $10.13 | $14 K | 198,646 | Form 4 |
| filed | Column Group III, LP10% owner | Conversionindirect | +4.39 M | — | — | 4.41 M | Form 4 |
| filed | JeenJoo KangDirector | Conversion | +12,500 | — | — | 25,000 | Form 4 |
| filed | Casdin Private Growth Equity Fund, L.P.10% owner | Conversionindirect | +2.37 M | — | — | 2.37 M | Form 4 |
| filed | Eli CasdinDirector, 10% owner | Conversionindirect | +2.37 M | — | — | 2.37 M | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Conversionindirect | +4.39 M | — | — | 4.41 M | Form 4 |
| filed | David V. GoeddelDirector, 10% owner | Conversionindirect | +4.96 M | — | — | 4.99 M | Form 4 |
| filed | Eli CasdinDirector, 10% owner | Buyindirect | +850,000 | $15.00 | $12.8 M | 3.22 M | Form 4 |
| filed | Casdin Private Growth Equity Fund, L.P.10% owner | Buyindirect | +850,000 | $15.00 | — | 3.22 M | Form 4 |
| filed | Column Group III, LP10% owner | Conversionindirect | +4.96 M | — | — | 4.99 M | Form 4 |
| filed | Eli CasdinDirector, 10% owner | Conversionindirect | +361,969 | — | — | 361,969 | Form 4 |
| filed | Casdin Private Growth Equity Fund, L.P.10% owner | Conversionindirect | +361,969 | — | — | 361,969 | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice